title: Can a single antibiotic policy for the empirical treatment of febrile neutropenic patients be used for all categories of haematology/oncology patient in the same institution?
authors.forename: B
authors.initials: B
authors.lastname: O'Connell
authors.forename: R
authors.initials: R
authors.lastname: Marcus
authors.forename: V
authors.initials: V
authors.lastname: Broadbent
authors.forename: M V
authors.initials: MV
authors.lastname: Williams
authors.forename: H
authors.initials: H
authors.lastname: Ludlam
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D016470:Bacteremia / Q000188:drug therapy* / Q000382:microbiology; D002648:Child; D004363:Drug Utilization; D005334:Fever / Q000209:etiology; D006402:Hematologic Diseases / Q000150:complications*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications*
chemical_list: D000900:Anti-Bacterial Agents